News

1. March 2007 15:20

European Science Foundation Publishes Forward Look Report on Nanomedicine

The European Science Foundation recently concluded a foresight study on the topic of nanotechnology applied to medicine (Scientific Forward Look on Nanomedicine). The goal of this Forward Look was to exchange views on the current status of Nanomedicine between scientific experts and policy makers, and to reflect upon future developments, opportunities and challenges facing this important field in Europe and world wide. Over 100 international experts from academia, industry, private foundations and governmental agencies supporting scientific research have contributed to this activity.

The European Science Foundation recently concluded a foresight study on the topic of nanotechnology applied to medicine (Scientific Forward Look on Nanomedicine). The goal of this Forward Look was to exchange views on the current status of Nanomedicine between scientific experts and policy makers, and to reflect upon future developments, opportunities and challenges facing this important field in Europe and world wide. Over 100 international experts from academia, industry, private foundations and governmental agencies supporting scientific research have contributed to this activity.

The ESF Forward Look on Nanomedicine has led to a definition of the current status of the field and debates on strategic policy issues. An ESF Policy Briefing, which summarises recommendations from this Forward Look activity, is going to be published on 1 March 2005 SPB23Nanomedicine. This policy paper provides only a brief summary of in-depth discussions throughout the foresight study. A full report documenting the detailed debate and analysis will be published separately.

Implementation of recommendations from the ESF Scientific Forward Look on Nanomedicine would strengthen Europe’s leading-edge research and ensure further development in Nanomedicine, resulting in reduced healthcare costs and the rapid realisation of medical benefits for all European citizens.

CONTACT

For more information about the ESF Forward Look on Nanomedicine and the conclusions please contact the following:

Mr. Jens Degett 

For expert’s opinions, the following Members of the Steering Committee may be contacted

Professor Ruth Duncan
Center for Polymer Therapeutics
Welsh School of Pharmacy
United Kingdom
Phone +44 (0)29 2087 4180
Fax +44 (0)2920874536

Expertise: Pharmaceutical and Clinical Applications of nanotechnology

Dr. Wolfgang Kreyling
GSF National Research Centre for Environment and Health
Phone+49 89 3187 2309
Fax+49 89 3187 3397

Expertise: Nanoparticles: applications and the toxicology. 

Professor Hans Oberleithner
Institute of Physiology
University of Münster
Phone +49 251 83 555 40
Fax +49 251 83 55 331

Expertise: Nano Imaging at the Molecular Level

Dr. Alberto A. Gabizon
Shaare Zedek Medical Center and Hebrew University-Faculty of Medicine
Jerusalem Israel
Phone +972 2 655 5036
Fax +972 2 652 1431

Expertise: liposomes and nanomedicines in clinical use, especially in cancer treatment